The role of ubiquitination in tumorigenesis and targeted drug discovery

L Deng, T Meng, L Chen, W Wei, P Wang - Signal transduction and …, 2020 - nature.com
Ubiquitination, an important type of protein posttranslational modification (PTM), plays a
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …

[HTML][HTML] Roles of F-box proteins in cancer

Z Wang, P Liu, H Inuzuka, W Wei - Nature reviews Cancer, 2014 - nature.com
F-box proteins, which are the substrate-recognition subunits of SKP1–cullin 1–F-box protein
(SCF) E3 ligase complexes, have pivotal roles in multiple cellular processes through …

[HTML][HTML] SCF ubiquitin ligase-targeted therapies

JR Skaar, JK Pagan, M Pagano - Nature reviews Drug discovery, 2014 - nature.com
The clinical successes of proteasome inhibitors for the treatment of cancer have highlighted
the therapeutic potential of targeting this protein degradation system. However, proteasome …

[HTML][HTML] EZH2 oncogenic mutations drive epigenetic, transcriptional, and structural changes within chromatin domains

MC Donaldson-Collier, S Sungalee, M Zufferey… - Nature …, 2019 - nature.com
Chromatin is organized into topologically associating domains (TADs) enriched in distinct
histone marks. In cancer, gain-of-function mutations in the gene encoding the enhancer of …

Degrons in cancer

B Mészáros, M Kumar, TJ Gibson, B Uyar… - Science …, 2017 - science.org
Degrons are the elements that are used by E3 ubiquitin ligases to target proteins for
degradation. Most degrons are short linear motifs embedded within the sequences of …

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth

M Niu, J Xu, Y Liu, Y Li, T He, L Ding, Y He, Y Yi… - Nature …, 2021 - nature.com
Abnormal activation of epidermal growth factor receptor (EGFR) drives non-small cell lung
cancer (NSCLC) development. EGFR mutations-mediated resistance to tyrosine-kinase …

KrasG12D and Nkx2-1 haploinsufficiency induce mucinous adenocarcinoma of the lung

Y Maeda, T Tsuchiya, H Hao… - The Journal of …, 2012 - Am Soc Clin Investig
Mucinous adenocarcinoma of the lung is a subtype of highly invasive pulmonary tumors and
is associated with decreased or absent expression of the transcription factor NK2 homeobox …

Emerging therapies targeting the ubiquitin proteasome system in cancer

NM Weathington, RK Mallampalli - The Journal of clinical …, 2014 - Am Soc Clin Investig
The ubiquitin proteasome system (UPS) is an essential metabolic constituent of cellular
physiology that tightly regulates cellular protein concentrations with specificity and precision …

[HTML][HTML] F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

DS Tekcham, D Chen, Y Liu, T Ling, Y Zhang… - Theranostics, 2020 - ncbi.nlm.nih.gov
E3 ubiquitin ligases play a critical role in cellular mechanisms and cancer progression. F-
box protein is the core component of the SKP1-cullin 1-F-box (SCF)-type E3 ubiquitin ligase …

[HTML][HTML] A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation

BB Chen, TA Coon, JR Glasser, BJ McVerry… - Nature …, 2013 - nature.com
Uncontrolled activation of tumor necrosis factor receptor–associated factor (TRAF) proteins
may result in profound tissue injury by linking surface signals to cytokine release. Here we …